Research Article
QSPR Study and Distance-Based New Topological Descriptors of Some Drugs Used in the COVID-19 Treatment
Table 14
Various physicochemical properties of COVID-19 drugs.
| Drugs | BP | E | FP | MR | PSA | | T | MV | IC50 |
| Arbidol | 591.8 | 91.5 | 311.7 | 121.9 | 80 | 48.3 | 45.3 | 347.3 | 3.54 | Chloroquine | 460.6 | 72.1 | 232.3 | 97.4 | 28 | 38.6 | 44 | 287.9 | 1.38 | Hydroxychloroquine | 516.7 | 83 | 266.3 | 99 | 48 | 39.2 | 49.8 | 285.4 | 0.72 | Lopinavir | 924.2 | 140.8 | 512.7 | 179.2 | 120 | 71 | 49.5 | 540.5 | 5.25 | Remdesivir | — | — | — | 149.5 | 213 | 59.3 | 62.3 | 409 | 0.987 | Ritonavir | 947 | 144.4 | 526.6 | 198.9 | 202 | 78.9 | 53.7 | 581.7 | 8.63 | Thalidomide | 487.8 | 79.4 | 248.8 | 65.2 | 87 | 25.9 | 71.6 | 161 | — | Theaflavin | 1003.9 | 153.5 | 336.5 | 137.3 | 218 | 54.4 | 138.6 | 301 | 8.44 |
|
|